Global Veterinary Products for Livestock Animals Market Size By Type (Medicines, Vaccine), By Application (Poultry, Pig), By Region, And Segment Forecasts, 2023 to 2032

The Global Veterinary Products for Livestock Animals Market was valued at USD 28.4 billion in 2023 and is expected to reach USD 45.7 billion by 2031, growing at a CAGR of 6.2% during the forecast period from 2023 to 2031. This growth is fueled by the increasing global demand for animal protein, rising incidences of zoonotic diseases, expanding livestock populations, and the rising awareness about animal health and productivity. Veterinary products—such as vaccines, feed additives, parasiticides, and antibiotics—play a vital role in ensuring the health and welfare of livestock, thereby supporting sustainable food systems and boosting farm profitability.

Drivers:

1. Rising Demand for Animal-Derived Food Products:

The global increase in the consumption of meat, milk, and dairy products has placed pressure on livestock producers to ensure animal health and productivity. This has directly led to increased use of veterinary pharmaceuticals, vaccines, and nutritional supplements.

2. Growing Livestock Population and Commercial Farming:

As economies in Asia-Pacific, Latin America, and Africa expand, there has been a rapid rise in livestock rearing, especially under organized farming systems. This transition has intensified the adoption of advanced veterinary care products.

3. Increasing Awareness and Government Initiatives:

Governments and health organizations are investing in awareness campaigns about animal health and vaccination programs, significantly driving market penetration, especially in emerging economies.

Restraints:

1. Stringent Regulatory Approvals and Compliance:

Veterinary products require rigorous testing, certification, and compliance with regional and international safety regulations. These factors often delay product launches and inflate R&D costs.

2. Antimicrobial Resistance (AMR):

Widespread misuse of antibiotics in livestock farming has raised concerns about AMR. Regulatory crackdowns and consumer resistance are influencing demand for certain antimicrobials, thus impacting market dynamics.

Opportunity:

1. Surge in Preventive Healthcare and Nutraceuticals:

The market is seeing a shift toward preventive healthcare solutions, including probiotics, prebiotics, and herbal feed additives, as substitutes for antibiotics. This trend is opening new avenues for innovation and product diversification.

2. Digitization and Precision Livestock Farming:

Technological advancements such as smart livestock monitoring systems and AI-based diagnostics are enhancing disease surveillance and product usage efficiency, presenting growth opportunities for veterinary product providers.

Market by System Type Insights:

By product type, parasiticides accounted for the largest share in 2023, attributed to their routine use in preventing infections that impact livestock productivity. Vaccines are projected to witness the fastest growth, driven by increasing awareness of disease prevention and emerging threats like avian influenza and foot-and-mouth disease.

Market by End-use Insights:

Based on end-use, cattle represented the largest revenue segment in 2023, due to the global demand for beef and dairy products. The swine segment is also expected to grow significantly, particularly in Asia-Pacific, where pork is a major protein source.

Market by Regional Insights:

North America led the market in 2023, supported by a well-established animal healthcare infrastructure, strong veterinary awareness, and regulatory compliance. Asia-Pacific is forecast to be the fastest-growing region, with rapid livestock sector expansion in India, China, and Southeast Asia, alongside supportive government subsidies and programs.

Competitive Scenario:

Major players in the market include Zoetis Inc., Elanco Animal Health, Merck Animal Health, Boehringer Ingelheim, Ceva Santé Animale, Virbac, Phibro Animal Health Corporation, and Vetoquinol S.A. These companies are focusing on expanding their regional presence, investing in R&D, and launching innovative products. For instance:

In 2023, Zoetis launched a new broad-spectrum parasiticide for multi-species protection.

Elanco partnered with biotech firms in 2024 to develop next-generation livestock vaccines.

Boehringer Ingelheim expanded its veterinary production facility in Latin America in 2025 to meet growing regional demand.

Scope of Work – Global Veterinary Products for Livestock Animals Market

Key Market Developments:

2023: Zoetis launched “Parasyn,” a next-gen injectable parasiticide effective against resistant strains.

2024: Elanco Animal Health acquired a nutraceutical startup specializing in gut health for ruminants.

2025: Merck Animal Health introduced a digital livestock management platform integrating diagnostics and vaccine scheduling.

FAQs:

1) What is the current market size of the Global Veterinary Products for Livestock Animals Market?

The market was valued at USD 28.4 billion in 2023.

2) What is the major growth driver of the Global Veterinary Products for Livestock Animals Market?

The key driver is the rising demand for animal-derived food products and increasing awareness of livestock health.

3) Which is the largest region during the forecast period in the Global Veterinary Products for Livestock Animals Market?

North America holds the largest share in 2023, but Asia-Pacific is expected to grow the fastest.

4) Which segment accounted for the largest market share in the Global Veterinary Products for Livestock Animals Market?

Parasiticides accounted for the largest share by product type in 2023.

5) Who are the key market players in the Global Veterinary Products for Livestock Animals Market?

Key players include Zoetis Inc., Elanco Animal Health, Merck Animal Health, Boehringer Ingelheim, and Ceva Santé Animale.